Pro Medicus Limited (PMCUF)
OTCMKTS · Delayed Price · Currency is USD
122.08
+4.08 (3.46%)
At close: Feb 11, 2026
Pro Medicus Revenue
Pro Medicus had revenue of 115.79M AUD in the half year ending June 30, 2025, with 70.25% growth. This brings the company's revenue in the last twelve months to 241.13M, up 28.14% year-over-year. In the fiscal year ending June 30, 2025, Pro Medicus had annual revenue of 212.98M with 31.88% growth.
Revenue (ttm)
241.13M AUD
Revenue Growth
+28.14%
P/S Ratio
59.64
Revenue / Employee
1.83M AUD
Employees
132
Market Cap
9.59B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 212.98M | 51.48M | 31.88% |
| Jun 30, 2024 | 161.50M | 36.60M | 29.30% |
| Jun 30, 2023 | 124.90M | 31.44M | 33.64% |
| Jun 30, 2022 | 93.46M | 25.40M | 37.31% |
| Jun 30, 2021 | 68.06M | 11.24M | 19.79% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
Pro Medicus News
- 2 months ago - ASX 200 LIVE: ASX outage over as shares fall; AUB dives 16pc - The Australian Financial Review
- 2 months ago - Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript - Seeking Alpha
- 4 months ago - ASX 200 news from Monday 29th September 2025: Shares gain; Synlait sells North Island assets to Abbott; Novonix delivers mass-production; Pro Medicus unaffected by US tariffs. Follow live here. - The Australian Financial Review
- 4 months ago - Fortescue tops list of the ASX’s 10 strongest dividend stocks - The Australian Financial Review
- 5 months ago - ASX 200 Live: ASX wavers; RPMGlobal soars 25pc on Caterpillar deal, Fortescue trades ex-dividend - The Australian Financial Review
- 5 months ago - How this fundie used AI to short Guzman y Gomez – and won - The Australian Financial Review
- 6 months ago - Pro Medicus Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript - Seeking Alpha